Korean J Nephrol.  2008 Nov;27(6):743-746.

Metronidazole-Induced Toxic Encephalopathy in A Hemodialysis Patient: A Case Report

Affiliations
  • 1Department of Internal Medicine, Eulji University Hospital, Eulji University, Daejeon, Korea. minogiya@dreamwiz.com
  • 2Department of Radiology, Eulji University Hospital, Eulji University, Daejeon, Korea.

Abstract

Metronidazole, one of the mainstay drugs for the treatment of anaerobic infections and protozoal infections, may produce some serious neurological side effects. Seizure, peripheral neuropathy, dizziness, vertigo, ataxia, confusion, irritability, headache and tremor have been reported among patients receiving metronidazole, particularly among those receiving high dose of the drug. However, no specific dose adjustment is recommended for patients with renal or hepatic dysfunction receiving metronidazole because the accumulation of the drug and its metabolites can occur in terms of severity of illness and patient tolerability. Although metronidazole is significantly removed by hemodialysis, no specific dose recommendations are made for this patient population. Recently, we experienced metronidazole-induced encephalopathy in a patient with end-stage renal disease, which was diagnosed by brain magnetic resonance imaging (MRI). Herein, we report a case with a review of literature.

Keyword

Metronidazole; Encephalopathy; Hemodialysis

MeSH Terms

Ataxia
Brain
Dizziness
Headache
Humans
Kidney Failure, Chronic
Magnetic Resonance Imaging
Metronidazole
Neurotoxicity Syndromes
Peripheral Nervous System Diseases
Renal Dialysis
Seizures
Tremor
Vertigo
Metronidazole
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr